Imatinib as a Tool Against COVID-19: A Balancing Act Between Effectiveness and Cardiac Safety.

Spadafora, Luigi; Bernardi, Marco; Biondi-Zoccai, Giuseppe; Peruzzi, Mariangela

Spadafora, Luigi; Bernardi, Marco; Biondi-Zoccai, Giuseppe; Peruzzi, Mariangela.

Afiliação

Spadafora L; Department of Clinical, Internal Medicine, Anesthesiology and Cardiovascular Sciences, Sapienza University of Rome, Rome, Italy.
Bernardi M; Department of Clinical, Internal Medicine, Anesthesiology and Cardiovascular Sciences, Sapienza University of Rome, Rome, Italy.
Biondi-Zoccai G; Department of Medical-Surgical Sciences and Biotechnologies, Sapienza University of Rome, Rome, Italy; and.
Peruzzi M; Mediterranea Cardiocentro, Naples, Italy.

J Cardiovasc Pharmacol ; 80(6): 779-780, 2022 12 01.

Article em En | MEDLINE | ID: mdl-35998027

Assuntos

COVID-19; Humanos; Mesilato de Imatinib/efeitos adversos; Coração

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: COVID-19 Limite: Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google